{
    "clinical_study": {
        "@rank": "100905", 
        "acronym": "PONV", 
        "arm_group": {
            "arm_group_label": "Ramosetron", 
            "arm_group_type": "Active Comparator"
        }, 
        "brief_summary": {
            "textblock": "To compare postoperative nausea and vomiting (PONV) and perioperative outcomes of\n      gynecologic patients undergoing laparoscopic surgery after scheduled administration of\n      intravenous Ramosetron during hospital stays.\n\n        -  Randomized controlled arm : Placebo versus Ramosetron injection\n\n        -  Administration schedule : immediate postoperative status, 12 hrs after surgery, 36hrs\n           after surgery"
        }, 
        "brief_title": "Long Term Prevention of Nausea and Vomiting in Gynecologic Laparoscopy", 
        "condition": "Uterine Myoma, Ovary Neoplasm, Adenomyosis", 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Nausea", 
                "Ovarian Neoplasms", 
                "Leiomyoma", 
                "Myofibroma", 
                "Vomiting"
            ]
        }, 
        "detailed_description": {
            "textblock": "Surgical outcomes including operative time, blood loss, Hb change, postoperative pain,\n      nausea/vomiting scale, times of rescue therapy, and complications"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age: 18< or =,   = or <70 with benign gynecologic disease\n\n          -  ASA-Class I-II\n\n          -  No-definite malignancy by US, CT/MRI, CA 125 < 500IU/ml\n\n          -  Non-smoker\n\n        Exclusion Criteria:\n\n          -  Conversion to laparotomy\n\n          -  Hx of malignancy\n\n          -  Smoker\n\n          -  Suspicious malignancy"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "128", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02011659", 
            "org_study_id": "PONV-NHIS-GYN-001"
        }, 
        "intervention": {
            "arm_group_label": "Ramosetron", 
            "intervention_name": "Ramosetron", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Ramosetron"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Ramosetron, postoperative nausea and vomiting, laparoscopy", 
        "lastchanged_date": "December 12, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Goyang-si", 
                    "country": "Korea, Republic of", 
                    "zip": "410-719"
                }, 
                "name": "National Health Insurance Service Ilsan Hospital"
            }, 
            "investigator": {
                "last_name": "San-Hui Lee, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Randomized Prospective Study of Scheduled Intravenous Ramosetron for the Prevention of Nausea and Vomiting in Hospitalized Patients After Gynecologic Laparoscopy", 
        "overall_contact": {
            "email": "sanaram@naver.com", 
            "last_name": "San-Hui Lee, M.D.", 
            "phone": "+82-900-0218"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Ministry for Health, Welfare and Family Affairs", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Incidence or intensity of PONV", 
            "safety_issue": "No", 
            "time_frame": "during postoperative hospital stays (2 days)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02011659"
        }, 
        "responsible_party": {
            "investigator_affiliation": "National Health Insurance Service Ilsan Hospital", 
            "investigator_full_name": "San-Hui Lee", 
            "investigator_title": "Clinical assistant professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Adverse reaction associated with Ramosetron injection", 
            "safety_issue": "Yes", 
            "time_frame": "Postoperatvie 7 days (at OPD based)"
        }, 
        "source": "National Health Insurance Service Ilsan Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Health Insurance Service Ilsan Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}